About Accunea
Accunea is a Healthcare company based in London (United Kingdom) founded in 2017. Monitoring devices for kidney function are developed by Accunea. Accunea has raised $258.15 thousand across 2 funding rounds. The company has 1 employees. Its chief executive, as recorded, is Nick Housby. Accunea offers products and services including Accunea Monitoring System and AI Trend Analysis Tool. Its focus areas include Life Sciences, Nephrology, Medical Devices and Monitoring Devices. Its legal entity is ACCUNEA LTD.
Company details
Accunea was founded in 2017 in London, United Kingdom, within the medical device sector. A microsensor array is developed to enable continuous real-time monitoring of kidney function biomarkers. Information on transplant organ performance is provided at the point of care. An AI system is utilized for population-based comparisons and early alerts. Operations focus on innovative assays for established functional markers in renal health.
- Headquarters London, United Kingdom
- Employees 1
- SectorsHealthcare
- Email••••••••
- Website accunea.com
- Social LinkedIn
- Legal Name Accunea Ltd.
- Date of Incorporation 09 Mar, 2017
- Jurisdiction KIDDERMINSTER, WORCESTERSHIRE
- Total Equity Funding$258.15K (USD)
in 2 rounds
- Latest Funding Round$121.87K (USD), Seed
Aug 2022
- Employee Count1
Products & Services of Accunea
Accunea offers a comprehensive portfolio of products and services, including Accunea Monitoring System and AI Trend Analysis Tool.
Monitors biomarkers for kidney transplant viability and patient recovery.
Provides AI insights on organ function trends during transplants.
Funding Insights of Accunea
Accunea has successfully raised a total of $258.15K across 2 strategic funding rounds. The most recent funding activity was a Seed round of $121.87 thousand completed in August 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $258,151
- Total Rounds 2
- Last Round Seed — $121,873
- First Round $136,278
(Jan 2021)
All 2 funding rounds of Accunea with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2022 | $121,873 | Seed | – | – | – |
| Jan 2021 | $136,278 | Seed | – | – | – |
People of Accunea
1 people are tracked at Accunea (1 in leadership); the tracked headcount is 1.
| Name | Role | Group |
|---|---|---|
Nick Housby | CEO | Leadership |
Complete people profiles for Accunea
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Accunea
3 dated milestones of Accunea across 5 years, from founding to its latest funding, stage changes and deals.
- Founded Accunea is founded.
- Funding First funding round of $136K.
- Funding Latest funding round, Seed, of $122K.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Accunea
Accunea was founded in 2017 and raised its 1st funding round 4 years after it was founded.
Accunea is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Nick Housby is the CEO of Accunea, as recorded in our data.
Accunea is a funded company, having raised a total of $258.15K across 2 funding rounds to date. The company's 1st funding round was a Seed of $136.28K, raised on Jan 2021.
Accunea has 1 employees.
Accunea was founded in 2017 in London, United Kingdom, within the medical device sector. A microsensor array is developed to enable continuous real-time monitoring of kidney function biomarkers. Information on transplant organ performance is provided at the point of care. An AI system is utilized for population-based comparisons and early alerts. Operations focus on innovative assays for established functional markers in renal health.
Accunea offers Accunea Monitoring System and AI Trend Analysis Tool.
Accunea operates through Accunea Ltd..